Opportunities
Search

Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26 MSRP CTA focus areas. Clinical trials may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies.Distinctive Features: The FY26 CTA offers two funding levels. The following are generalized descriptions of the scope of research appropriate for each funding level:• Funding Level 1 (CTA-FL1) supports small-scale, proof-of-principle clinical trials (e.g., pilot, first-in-human, phase 0) to demonstrate feasibility or inform the design of more advanced trials, or other clinical trials that are appropriate for this funding level. Preliminary data relevant to the proposed clinical trial are required.• Funding Level 2 (CTA-FL2) supports larger-scale clinical trials at phase 1 or phase 2 that seek to show preliminary evidence of safety or efficacy (i.e., benefit of clinical or paraclinical outcomes) in relevant patient populations. Clear description and justification should be provided, which could include, but is not limited to, the intervention type, trial duration, sample size, outcome measures, assessment tools and frequency of assessment. Preliminary data relevant to the proposed clinical trial in MS populations are required.For the purposes of this funding opportunity, Regulat...

Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Exploration – Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the Multiple Sclerosis (MS) research field. The studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. All applications must address at least one of the FY26 MSRP EHDA focus areas. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is not required.Distinctive Features: This funding mechanism includes two options: Established Investigator and New Investigator. The New Investigator option supports applicants early in their faculty appointments.

Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Early Investigator Research Award (EIRA) supports Multiple Sclerosis-focused research opportunities for individuals in the early stages of their careers, under the guidance of one or more designated Mentors. All applications must address at least one of the FY26 MSRP EIRA focus areas.Distinctive Features: This opportunity allows for early-stage investigators to develop a research project, investigate a problem or question in MS research, and further their intellectual development as an MS researcher of the future. All application components for the EIRA are expected to be written by the Principal Investigator (PI), with appropriate direction from the Mentor(s).

Buyer: OSAKIDETZA - Servicio Vasco de Salud - OSI Barakaldo-Sestao (Impulsora) | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: MKB Fastighets Aktiebolag | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Commune de Chiconi (976) | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-08-14

Buyer: Reisen Service Omnibusverkehre GmbH | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-14

Buyer: NOALIS | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: ΔΗΜΟΣ ΣΠΑΡΤΗΣ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-14

Buyer: GRAND POITIERS CENTRALE D'ACHATS | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Office fédéral des routes OFROU, Division Infrastructure routière Ouest, filiale Estavayer-le-Lac | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-08-14

Buyer: Bergen kommune - Innkjøp konsern | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-14

Buyer: Openbare Vlaamse Afvalstoffenmaatschappij | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Fonds de Compensation | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Havforskningsinstituttet | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Commune d'Eze (06) | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-08-14

Buyer: Spitalul Clinic Dr. I. Cantacuzino | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Enebakk Kommune | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Universitetet i Oslo | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: gemeente Schouwen-Duiveland | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-14

Buyer: Danmarks Tekniske Universitet - DTU | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-14

Buyer: NGIR Drift AS | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: Centre Hospitalier Saint-Pierre | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-08-14

Buyer: Aktieselskapet Vinmonopolet | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-08-14

Buyer: DÉPARTEMENT DE MAINE ET LOIRE | Notice type: cn-social | Procedure: oth-single | Contract: services | Deadline: 2026-08-14